848 related articles for article (PubMed ID: 26488693)
1. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
[No Abstract] [Full Text] [Related]
5. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
Barton MK
CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
[No Abstract] [Full Text] [Related]
6. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
Hajdenberg J
Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
[No Abstract] [Full Text] [Related]
7. Nicotinamide for skin cancer chemoprevention.
Damian DL
Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
[TBL] [Abstract][Full Text] [Related]
8. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
Minocha R; Damian DL; Halliday GM
Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide for Skin-Cancer Chemoprevention.
Drago F; Ciccarese G; Parodi A
N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
[No Abstract] [Full Text] [Related]
10. Nicotinamide for Skin-Cancer Chemoprevention.
Zhao Y
N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
[No Abstract] [Full Text] [Related]
11. Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Damian DL
N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
[No Abstract] [Full Text] [Related]
12. Skin cancer: Nicotinamide reduces new skin cancer risk.
Sidaway P
Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
[No Abstract] [Full Text] [Related]
13. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
Surjana D; Halliday GM; Martin AJ; Moloney FJ; Damian DL
J Invest Dermatol; 2012 May; 132(5):1497-500. PubMed ID: 22297641
[No Abstract] [Full Text] [Related]
14. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
Mainville L; Smilga AS; Fortin PR
J Cutan Med Surg; 2022; 26(3):297-308. PubMed ID: 35134311
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
17. Nicotinamide: New Indications in Dermatology.
Escudero-Góngora MM; Fernández-Peñas P
Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
[No Abstract] [Full Text] [Related]
18. Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Arzeno J; Leavitt E; Lonowski S; Kim J
Dermatol Surg; 2021 Jul; 47(7):995-997. PubMed ID: 33587370
[No Abstract] [Full Text] [Related]
19. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide: An Update and Review of Safety & Differences from Niacin.
Huber R; Wong A
Skin Therapy Lett; 2020 Nov; 25(5):7-11. PubMed ID: 33196157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
